Insider Transactions in Q1 2023 at Catalyst Pharmaceuticals, Inc. (CPRX)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 29
2023
|
Alicia Grande VP, Treasurer and CFO |
SELL
Open market or private sale
|
Direct |
50,000
-20.41%
|
$800,000
$16.7 P/Share
|
|
Mar 29
2023
|
Alicia Grande VP, Treasurer and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+33.21%
|
$50,000
$1.13 P/Share
|
|
Mar 29
2023
|
Jeffrey Del Carmen Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
40,000
-72.58%
|
$640,000
$16.7 P/Share
|
|
Mar 29
2023
|
Jeffrey Del Carmen Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
40,000
+42.06%
|
$120,000
$3.23 P/Share
|
|
Mar 28
2023
|
Alicia Grande VP, Treasurer and CFO |
SELL
Open market or private sale
|
Direct |
58,216
-17.26%
|
$931,456
$16.51 P/Share
|
|
Mar 28
2023
|
Alicia Grande VP, Treasurer and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
58,216
+34.86%
|
$0
$0.79 P/Share
|
|
Mar 22
2023
|
Alicia Grande VP, Treasurer and CFO |
SELL
Open market or private sale
|
Direct |
41,784
-24.65%
|
$668,544
$16.46 P/Share
|
|
Mar 22
2023
|
Alicia Grande VP, Treasurer and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
41,784
+17.95%
|
$0
$0.79 P/Share
|
|
Mar 20
2023
|
Brian Elsbernd Chief Compliance/Legal Officer |
SELL
Open market or private sale
|
Direct |
50,000
-26.59%
|
$800,000
$16.07 P/Share
|
|
Mar 20
2023
|
Brian Elsbernd Chief Compliance/Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+21.0%
|
$50,000
$1.13 P/Share
|
|
Feb 15
2023
|
Gary Ingenito Chief Med. & Reg. Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,435
-5.97%
|
-
|
|
Feb 15
2023
|
Gary Ingenito Chief Med. & Reg. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+19.68%
|
-
|
|
Feb 15
2023
|
Richard J Daly President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+3.92%
|
-
|
|
Feb 15
2023
|
Jeffrey Del Carmen Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,125
-29.3%
|
-
|
|
Feb 15
2023
|
Jeffrey Del Carmen Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,666
+50.0%
|
-
|
|
Feb 15
2023
|
David S Tierney Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+1.26%
|
-
|
|
Feb 15
2023
|
Philip H Coelho Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+2.52%
|
-
|
|
Feb 15
2023
|
Donald A Denkhaus Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+1.19%
|
-
|
|
Feb 15
2023
|
Patrick J Mcenany Director |
SELL
Payment of exercise price or tax liability
|
Direct |
14,204
-0.36%
|
-
|
|
Feb 15
2023
|
Patrick J Mcenany Director |
BUY
Exercise of conversion of derivative security
|
Direct |
58,333
+1.45%
|
-
|
|
Feb 15
2023
|
Alicia Grande VP, Treasurer and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,718
-5.1%
|
-
|
|
Feb 15
2023
|
Alicia Grande VP, Treasurer and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
11,166
+17.33%
|
-
|
|
Feb 15
2023
|
Molly Harper Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+50.0%
|
-
|
|
Feb 15
2023
|
Charles B O'Keeffe Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+0.64%
|
-
|
|
Feb 15
2023
|
Steve Miller Chief Op. & Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,666
+2.27%
|
-
|
|
Feb 15
2023
|
Preethi Sundaram Chief Strategy Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,024
-36.15%
|
-
|
|
Feb 15
2023
|
Preethi Sundaram Chief Strategy Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
16,666
+50.0%
|
-
|
|
Feb 15
2023
|
Brian Elsbernd Chief Compliance/Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,353
-1.68%
|
-
|
|
Feb 15
2023
|
Brian Elsbernd Chief Compliance/Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,666
+6.44%
|
-
|
|
Jan 24
2023
|
Donald A Denkhaus Director |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+13.19%
|
$0
$0.79 P/Share
|
|
Jan 24
2023
|
Charles B O'Keeffe Director |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+7.5%
|
$0
$0.79 P/Share
|